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Abstract
Hypertrichosis is defined as an excessive growth in body hair beyond the normal variation compared with
individuals of the same age, race and sex and affecting areas not predominantly androgen-dependent. The term
hirsutism is usually referred to patients, mainly women, who show excessive hair growth with male pattern
distribution.
Hypertrichosis is classified according to age of onset (congenital or acquired), extent of distribution (generalized or
circumscribed), site involved, and to whether the disorder is isolated or associated with other anomalies. Congenital
hypertrichosis is rare and may be an isolated condition of the skin or a component feature of other disorders.
Acquired hypertrichosis is more frequent and is secondary to a variety of causes including drug side effects,
metabolic and endocrine disorders, cutaneous auto-inflammatory or infectious diseases, malnutrition and anorexia
nervosa, and ovarian and adrenal neoplasms. In most cases, hypertrichosis is not an isolated symptom but is
associated with other clinical signs including intellective delay, epilepsy or complex body malformations.
A review of congenital generalized hypertrichosis is reported with particular attention given to the disorders where
excessive diffuse body hair is a sign indicating the presence of complex malformation syndromes. The clinical
course of a patient, previously described, with a 20-year follow-up is reported.
Introduction
In the normal individual, hair follicles are enclosed in
the skin with the exception of the palms, soles, and lips.
Hypertrichosis is defined as an excessive growth in body
hair beyond the normal variation compared with individ-
uals of the same age, race and sex and affecting areas
not predominantly androgen-dependent [1]. The term
hirsutism is usually reserved for patients, mainly female,
who show extensive hair growth in androgen-dependent
areas and with male pattern distribution [2]. The clinical
pattern of hypertrichosis can vary in individuals, ranging
from lanugo to vellous and terminal hairs. Lanugo refers
to long and unmedullated hairs; vellous hairs are unme-
dullated, short, soft and lightly pigmented and are often
seen on the face of infants; terminal hairs are produced
by follicles and appear medullated, dense and varying in
length, depending on the area [3–7].
Hypertrichosis is classified in different subgroups ac-
cording to age of onset (congenital or acquired), extent
of distribution (generalized or circumscribed), site in-
volved (elbow, neck, lumbosacral region) and to whether
isolated or associated with various abnormalities [8, 9].
Acquired generalized hypertrichosis may be secondary
to different causes, including drug side effects, metabolic
and endocrine disorders (hypothyroidism), dermatomyo-
sitis, infectious diseases, malnutrition and anorexia ner-
vosa, and ovarian and adrenal neoplasms [6]. The
acquired circumscribed form may be secondary to local
pressure, inflammatory lesions, inappropriate use of
cosmetics, and to hormonal or steroid stimulation of the
skin [7].
The aim of the present study is to offer a clinical sur-
vey of generalized congenital hypertrichosis (CGH) and
the most common malformation syndromes in which
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hypertrichosis is a presenting sign and a clue for the
diagnosis of the underlying disorders. The clinical course
of a patient previously described [10], with an updated
follow-up after 20 years is described.
Historical background
Individuals affected by hypertrichosis have been re-
corded since the Middle Age and the Renaissance. At
that time and in the following centuries, interest was
limited to their characteristic phenotype, and they were
often exhibited as unnatural phenomena in circuses and
fairs due to their peculiar aspect.
Julia Pastrana was a famous woman recognized as af-
fected by this disorder. She was an indigenous Mexican
dancer, exhibited in a circus in the United States in the
mid-19th century. When she arrived in Europe, Frank
Buckland described her as a normal female entirely cov-
ered by hair of variable length, sparing her palms and
soles [11]. She presented noticeable gingival hyperplasia,
a sign that in the following clinical reports would be
considered as a feature often associated with hypertri-
chosis [6, 7].
In the 19th century, the Russian Adrian Jeftichew and
his son Fedor, were affected by the same clinical features
as the individuals reported above. They presented hyper-
trichosis on the face and whole body, although the son
had less abundant facial hair. In both, hands and feet
were spared, together with the anterior portion of the
neck and internal face of the arms. In particular, the
dentition of Adrian was reported to be partial with sev-
eral teeth missing [12].
Epidemiology
The incidence of CGH is unknown, but held to be es-
sentially rare. The incidence is notably higher when the
hypertrichosis is one of several signs involved in a com-
plex syndrome. In this case, the incidence of CGH is re-
lated to the single condition associated with it [12].
Etiopathogenesis
CGH in its most common form is idiopathic in the ab-
sence of underlying endocrine or metabolic disorders. It
is assumed to be related to an excess of stimulation of
the hair follicles with normal levels of androgen-like hor-
mones [1]. To date, a clear specific molecular abnormity
has not been proved. A hypothesis has been advanced to
explain the typical phenotypic aspect of these patients:
an atavistic reversion of a suppressed ancestral gene. In
the course of evolution genes causing hair growth have
been silenced and the appearance of hair in healthy
humans can be explained by an erroneous reactivation
of such genes [13–15]. In idiopathic CGH, an autosomal
dominant trait inheritance with two or more members
of the same family affected [16], an X-linked [17] and an
autosomal recessive [6, 7] pattern of inheritance have
been described. The involvement of chromosome 8 has
been reported in patients with generalized congenital
hypertrichosis, Ambras type [8, 18, 19], and involvement
of chromosome X at the locus Xq24-q27.1 [20] in a fam-
ily where the males were more affected than the females.
CGH is known to be associated with intellective delay,
epilepsy, and malformation features, involving different
areas of the body, including facial dysmorphism and ab-
normalities of eyes, heart, bones and kidneys. Specific
molecular defects have been reported in well-known
syndromes presenting with hypertrichosis. These include
Cornelia De Lange syndrome, with the involvement of
genes N11BL, SMC1A, SMC3, RAD21, and HDACE
[21]; Coffin-Siris syndrome (BAF complex genes) [22];
Wiedeman-Steiner syndrome (KMT2A gene) [23].
Diagnosis
Diagnosis of CGH is performed at first glance, but a de-
tailed review of patient history and an in-depth physical
examination are necessary to determine the presence of
other abnormalities beyond the cutaneous manifestation.
Particular attention should be given to the presence of
other anomalies in particular the face, eyes, teeth,
hearth, kidneys, bones, and extremities, and at the same
time, to obesity and intellectual disability. The diagnosis
directed at identifying the signs associated with CGH
and distinguishing it from the acquired form. The latter
group consists of a) drug induced hypertrichosis, in par-
ticular anti-convulsants such as phenytoin and other
drugs, including corticosteroids, cyclosporine and inter-
feron alpha 2; b) malnutrition and anorexia nervosa; c)
endocrine disorders, juvenile dermatomyositis and infec-
tious diseases; d) metabolic diseases such as mucopoly-
saccharidoses (Hurler, Hunter, Sanfilippo syndromes),
congenital porphyrias, and adrenal enzymatic deficiency;
e) ovarian and adrenal neoplasms [6]. Depending on the
clinical manifestations, laboratory analyses, skeletal X-
rays, Brain-MRI, ultrasound EEG, ECG and echocardio-
gram, and psychometric tests are useful investigations.
Congenital generalized hypertrichosis: clinical
forms
These forms are characterized by generalized hypertri-
chosis of the face, trunk and limbs, with very early onset
without signs of precocious puberty or virilization. They
are often associated with cognitive delay, failure to thrive
and signs of dysmorphism of the face and extremities
(diagnostic flow-chart in Fig. 1). In this review, we have
differentiated CGH as 1) isolated, 2) co-occurring with
others anomalies or neurological disorders, 3) in the set-
ting of well-known complex syndromes and 4) disorders
with hypertrichosis as an uncommon sign. It should be
underlined that some of these forms present common
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features with each other and some abnormalities could
be considered as variants of the same syndrome. These
syndromes and their genetic mutations are resembled in
Table 1.
CGH as most prominent feature
Congenital hypertrichosis lanuginosa (CHL)
CHL is characterized by the presence of fine, blond hair of
lanugo type, distributed all over the body except for the
palms, soles and mucous membranes [6, 11]. In normal
individuals, lanugo hairs are often present at birth and
tend to gradually disappear over the first months of life. In
affected patients, the lanugo distribution continues to pro-
gress, involving the whole body [7]. The disorder is also
known as “Ambras Syndrome” referring to the painting of
Peter Gonzales kept in Ambras Castle, Austria [11]. This
form has been reported in patients with abnormalities of
chromosome 8q [8, 18] and as autosomal dominant trait
inheritance but also as sporadic events. [7].
Congenital hypertrichosis universalis
In this disorder, patients show a clinical presentation
similar to CHL, with hairs distributed over the face,
trunk, back and limbs. The individuals affected present
with terminal hairs from birth. Familial cases have been re-
ported with autosomal dominant inheritance and X-linked
with a responsible gene mapped to Xq24-q27.1 [20].
CGH associated with other anomalies
CGH with gingival fibromatosis
In this form, alongside hypertrichosis, patients present
with gingival overgrowth, which is not related to any drug
treatment, including anticonvulsants and cyclosporine
[24]. In addition, the affected patients may present cogni-
tive delay and/or epilepsy [25–27]. Douzgou reported a
typical example of a patient with all those anomalies [28].
The gingival overgrowth may be diagnosed later. Patients
with de novo mutation and also with autosomal recessive
inheritance have been reported [29].
CGH with amaurosis congenita cone-rod type
A large family with an autosomal recessive inheritance
was reported by Jalili. [30]. The affected patients present
a clinical pattern of ocular anomalies, with Leber-type
retinal involvement, and cone-rod dystrophy. In addition,
Fig. 1 Diagnostic algorithm for Congenital Generalized Hypertrichosis
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the patients show trichomegaly, bushy eyebrows and
synophrys.
CAHMR syndrome
CGH has been also associated with congenital lamellar
cataracts and mental retardation, with the acronym
CAHMR syndrome. Additional features consist of
macrodontia and pectus excavatum. In a family, an
autosomal recessive inheritance was suggested [31].
Pigmentary retinopathy
In 1996, Pivnick et al reported on a 22-month-old child
who showed diffuse hypertrichosis, facial structural
anomalies, symmetrical hyperpigmentation of the side-
burn areas of the face and hyperpigmented streaks on
the limbs, dolicocephaly and pigmentary retinopathy.
The hyperpigmented skin showed histological features
of many separate bundles of smooth muscles in the
derma [32].
Zimmermann-Laband syndrome
The syndrome is characterized by gingival hypertrophy,
hypo/aplastic nails and distal phalanges, hypertrichosis and
intellectual disability. Hypertrichosis is a presenting sign.
Molecular anomalies are not known. An autosomal domin-
ant with high mutation rate and rare instances of germinal
mosaicism are reported as expression of inheritance [33].
Hypertrichosis with coarse face, obesity, short stature and
brachydactily
In 1996, some of the authors of the present article, de-
scribed a patient who showed CGH, coarse facial features,
obesity and, moreover, short stature, brachydactily with
broad proximal phalanges and small, dysmorphic nails [10].
Table 1 Syndromes presenting with Generalized Hypertrichosis and related genetic mutations. Legend: CGH: congenital generalized
hypertrichosis
Disease Genes involved (location)
Congenital generalized hypertrichosis
as most prominent feature
Congenital hypertrichosis lanuginosa Inverse mutation on the 8q chromosome
Congenital hypertrichosis universalis Autosomal dominant mutation in Xq24-q27.1
Congenital generalized hypertrichosis
associated with other anomalies
CGH with gingival fibromatosis Unknown
CGH with amaurosis congenita cone-rod type Unknown




Zimmermann-Laband syndrome Probable breakpoint location in 3p14.3
Hypertrichosis with coarse face, obesity, short
stature and brachydactily
Unknown
Congenital hypertrichosis as a component
feature of complex syndromes
Cornelia de Lange syndrome NIPBL (5p13.2); SMC1A (Xp11.22-p11.21); SMC3 (10q25);
RAD21 (8q24.11); HDAC8 (Xq13)
Coffin-Siris syndrome BAF complex genes (19p13.2; 22q11.23; 9p24.3; 17q21.2;
1p36.11; 6q25.3)
Barber-Say syndrome KMT2A (11q23)
Acromegaloid facial appearance with
hypertrichosis
PGM1 (1p22.1); GLO1 (6p21.3-p21.1), IGHG3 (14q32.33),
and HP (16q22.2) [low positive LOD scores for linkage]




Berardinelli-Seip congenital lipodystrophy BSCL (11q13)
Donohue syndrome INSR (19p13.2)
Torg-Winchester syndrome and nodulosis
arthropathy-osteolysis
MMP2 (16q13-q21)
Rubinstein-Taybi syndrome CREBBP (16p13.3); EP300 (22q13.2)
Schinzel-Giedion syndrome SETBP1 (18q21.1)
Gorlin-Chaudry-Moss syndrome Unknown
Disorders with congenital generalized
hypertrichosis as an uncommon feature
Hemi-maxillo facial dysplasia Unknown
Craniofacial dysostosis Unknown
Hypomelanosis of Ito Probable breakpoint location in Xp11
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Congenital hypertrichosis as a component feature of
complex syndromes
Cornelia de Lange syndrome
In this syndrome, generalized hypertrichosis is present
together with cutis marmorata in 60 % of patients; the
cutaneous signs are small nipples and umbilicus and
premature aging signs (wrinkling, sagging and gray hair)
[34]. Microcephaly, short neck, and a characteristic fa-
cies consisting in low anterior and posterior hairlines,
arched eyebrows and synophrys, narrow palpebral fis-
sures and long, curly eyelashes are the presenting signs
of the syndrome. Thick, low set and posteriorly rotated
ears, flat midface, short broad nose and depressed nasal
bridge with anteverted nares, down-turned corners of
the mouth and micrognathia are often observed. High
and cleft palate (often submucous) and dental anomalies
may be present. Patients affected by this syndrome often
show prenatal and postnatal growth retardation, short
stature with short hands and feet and psychomotor
delay. Other signs are usually present: hearing loss, scoli-
osis, cervical malformations and pectus excavatum, early
osteoporosis and pyloric stenosis. In this syndrome, a
25-30 % incidence of congenital heart disease, 40 % of
structural kidney and/or urinary tract anomalies, 73 %
cryptorchidism and 57 % hypoplastic genitalia have been
reported [35]. Mutations in NIPBL, SMC1A, SMC3,
RAD21 and HDAC8 genes have been linked with this
syndrome [21].
Coffin-Siris syndrome
Patients with Coffin-Siris syndrome show signs of hyper-
trichosis, sparse scalp hair, bushy eyebrows and eye-
lashes. There is almost always an abnormal or delayed
dentition, together with ear anomalies and absence of
the distal phalanx and nails of the fifth fingers and toes.
Mutations in BAF complex genes are the main cause of
the syndrome [22, 36, 37].
Barber-Say syndrome
Aside hypertrichosis, patient with Barber-Say syndrome
present atrophic lax skin, macrostomia, broad and
coarse eyebrows, an hairy bulbous nasal tip with hypo-
plastic flaring nostrils, telecanthus and hypoplastic nip-
ples. Mutations in KMT2A gene have been found to be
the cause of the disorder [38–40].
Acromegaloid facial appearance with hypertrichosis
This rare syndrome is characterized by hypertrichosis ter-
minalis, coarse facies, bulbous nose, thickened lips, nar-
row palpebral fissures, thick intraoral mucosa, high arched
eyebrows, mental retardation (not always present), large
hands, hyperextensible joints, recurrent pericardial effu-
sions and hypotestosteronemia. Autosomal recessive in-
heritance has been suggested [41, 42].
Wiedemann-Steiner syndrome
Hypertrichosis and prominent forehead with low anter-
ior and posterior hairlines, thick eyebrows, hypertelor-
ism, wide nasal bridge and small ears are the main
features of the syndrome. Patients also show hypotonia,
short stature, markedly advanced bone age, hypoplastic
12th ribs and a dysplastic hip, doughy and redundant
skin on hands and hypoplastic middle phalanx of the
fifth finger. Mutations in KMT2A gene complex have
been found in the patients affected [23, 43].
Osteocondrodysplasia with hypertrichosis or Cantù
Syndrome
Patients show neonatal macrosomia, with wide posterior
fossa in the skull, a distinctive osteocondrodysplasia,
coarse face, cognitive delay and cardiomegaly with car-
diomyopathy. A mutation in the ABCC9 or with KCNJ8
gene has been reported [44–46]. The bone involvement
is complex with narrow thorax, broad ribs, platyspon-
dyly, hypoplastic idiopathic branches, small obturator
foramen, bilateral coxa valga, large medullary canals and
generalized osteopenia. Short distal phalanx of the
thumbs and of the first toes, delayed bone age and
hypertrophy of the first metatarsus are also found.
Berardinelli-Seip congenital lipodystrophy
This syndrome is an autosomal recessive disorder with
various dermatological features and systemic manifesta-
tions. Types 1 and 2 have been distinguished, with the
latter more common and severe, with onset in the neo-
natal period or in early infancy [47]. Lipoatrophic dia-
betes and generalized congenital hypertrichosis are the
main features of the syndrome. Patients present with a
distinctive facial appearance with sunken cheeks, large
ears, curly scalp hair and external genital hypertrophy
[48–50]. Diabetes is insulin-resistant without ketosis. In
this disorder, the hair tends to become more pro-
nounced with age. Cognitive delay, corneal opacities,
hepatomegaly and cardiac renal abnormalities are re-
ported [49, 50]. Other dermatologic features consist of
acanthosis nigricans, prominent subcutaneous veins and
xantomas. The locus for BSCL has been identified in
chromosome 11q13 [51].
Donohue syndrome (DS)
Also known as leprechaunism, DS is a severe form of
congenital insulin resistance, due to a mutation in the
insulin receptor gene. It is characterized by dwarfism
with a peculiar elfin-like face, large eyes, thick lips and
low set ears. Patients present with metabolic abnormal-
ities and increased levels of androgens, together with
loss of subcutaneous fat with excessive folding of the
skin [52]. Hypertrophy of external genitalia, abdominal
distension and slow growth may also be present.
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Donohue syndrome shows features similar to Berardinelli
Seip syndrome but its course is more severe and insulin re-
sistance is more precocious. The increased early mortality
is linked to anomalous energetic metabolism and loss of
glucose homeostasis. Tentative treatment with recombinant
human IGF1 has been started [52].
Torg-Winchester syndrome and nodulosis arthropathy-
osteolysis (NAO)
Nosographic delineation of these syndromes has not been
defined. Clinical manifestations include dwarfism, with
joint and bony abnormalities, peripheral corneal opacities,
and coarse facial features [53]. Localized thickened cuta-
neous plaques are reported. Bone abnormalities consist of
progressive osteolysis affecting the carpal, tarsal and inter-
phalangeal joints. Involvement of metalloproteinasis2 gene
(MMP2 gene) has been reported [54–60].
Rubinstein-Taybi syndrome (RTS)
RTS is an autosomal dominant disorder characterized by
typical features of bird-like facies and hypertelorism,
microcephaly, broad thumbs and big toes, cognitive
delay and postnatal growth retardation. Mutations in the
genes encoding the cyclic-AMP regulated enhanced
binding protein (CREBBP) and the E1A binding protein
p300 (EP300) have been found in patients with this syn-
drome [57–59].
Schinzel-Giedion syndrome (SGS)
The syndrome is characterized by multiple congenital
anomalies with craniofacial dysmorphism (midfacial re-
traction, protruding forehead) and severe cognitive
delay. The neck is short, with abundant folds of skin.
The gene involved in this disorder is SETBP1. The syn-
drome has been associated with various neurological ab-
normalities, including cobblestone lissencephaly and
epileptic seizures (West syndrome type). Radiological
bone abnormalities affect the skull, ribs and terminal
phalanxes [60, 61].
Gorlin-Chaudry-Moss syndrome
This congenital malformation syndrome is characterized
by craniofacial dysostosis (mid-facial flattening), under-
developed genitalia, patent ductus arteriosus and hypopla-
sia of teeth, and digital defects. To date, no pathological
deletions or duplications have been found [62, 63].
Disorders with CGH as an uncommon feature
Hemi-maxillo-facial dysplasia
In this disorder the face is asymmetric with unilateral
maxillar enlargement and with ipsilateral facial hypertri-
chosis. The teeth are hypoplastic [7].
Craniofacial dysostosis
Is often associated with cardiac anomalies, hypoplasia of
the labia majora, together with abnormalities of the teeth
and eyes [7].
Hypomelanosis of Ito
Is a complex cutaneous disorder characterized by hypo-
pigmented macular patches following the Blaschko lines
frequently associated with neurological impairment such
as cognitive delay and epilepsy. In one patient, the nor-
mal skin presented with hypertrichosis while the hypo-
melanotic areas did not [7, 64].
Prognosis
As discussed above, congenital generalized hypertricho-
sis is a clinical sign of different disorders. The distribu-
tion of hair is usually precocious and rarely progressive.
The prognosis is related to the pathological events asso-
ciated with the hair disorder, in particular to the epilepsy
and cardiac or renal anomalies.
Management and treatment of hypertrichosis
Congenital generalized hypertrichosis is cause of signifi-
cant emotional distress for the affected patients and their
family. The cosmetic embarrassment is particularly rele-
vant when the hair is widely distributed over the areas of
the body normally uncovered. There are different ap-
proaches to the treatment of excess hair, including:
1) cosmetic procedures
2) intense pulsed light source and laser treatment
3) pharmacological treatment
It should be underlined that not all the treatments are
effective over the long term, and the choice of therapy
should be made taking into consideration such aspects
as the location of the excess hair, its association with
complex anomalies and the age of the patients.
Cosmetic procedures consist of using bleaching
methods to make dark-colored hair less evident or of
using different procedures to remove the excess hair, such
as trimming, shaving, plucking or waxing. Clinical depil-
ation acts by damaging the hair directly on the skin sur-
face, while electrosurgical epilation, using a fine electric
needle inserted into the hair follicle, is more effective.
Important results are obtained by intense pulsed light
sources and various type of lasers (Ruby, Alexandrite,
Diode). In particular, a Neodynium:Yttrium-Albumin-
Garnet (Nd:YAG) laser has been used with appreciable
results in the removal of excess hair [65].
Pharmacological treatment consists of topical eflori-
nithine, a specific and irreversible inhibitor of the en-
zyme ornithine decarboxylase, which is located within
the hair follicle and stimulates hair growth [6, 66].
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When present in the setting of systemic disorders,
hypertrichosis treatment is usually linked to the associated
anomalies. Cosmetic treatment is always useful to avoid
the social rejection and isolation of patients. The use of
shaving or clinical hair removal may give excellent results
but it may also cause irritation and allergic contact derma-
titis. Good results can be achieved with electrolysis or
Alexandrite laser, but repeated sessions are usually re-
quired. In some cases, depilation may be definitive. In one
third of cases regrowth of the hair may occur, thus neces-
sitating further procedures.
Conclusions
Generalized congenital hypertrichosis is a wide topic in
the field of pediatric practice. Generalized congenital
hypertrichosis is not only a cause of cosmetic embarrass-
ment but also a clue to various complex syndromes.
Although this clinical event is rare, it can cover numer-
ous conditions, which can create genetic and prognostic
problems not only in the patient but in subsequent pro-
geny. In particular, the severe consequences of these disor-
ders necessitate a major effort to better define the clinical
focus and the pathogenesis and to develop pharmaco-
logical treatments aimed at making this pathology less
unpleasant.
Addendum
A 17-year-old male with hypertrichosis, coarse facial fea-
tures, brachydactily, obesity and intellectual delay was re-
ported by our group in 1996 [10]. The patient showed
generalized hypertrichosis of terminal hair from birth. The
hair was distributed along the body with a whorl-shaped
pattern in the middle of the back and the eyebrows were
thick. The face was round and coarse. The hands and feet
were small, the proximal phalanges broad and the nails
small and dyschromic. Intellectual delay was present.
We have periodically followed up this patient since the
age of 17 years for further 19 years. His general condition
has not changed. At the age of 20 years, he started to
present frequent episodes of generalized tonic-clonic sei-
zures, partially controlled by anticonvulsants (carbamaze-
pine) and for some years by levetiracetam with better
results. Intellective delay is moderate-severe. He is not ag-
gressive, lives at home but attends an institution for intel-
lective delay. He shaves twice a day. He was advised to
follow a diet, with poor compliance, and is still overweight.
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